glp-1 agonist and pancreatitis A new study showed that use of the GLP1 medications approved for diabetes weight loss including liraglutide (Victoza, Saxenda) & semaglutide (Ozempic, Wegovy, Rybelsus) come with a 9X increased risk GLP-1–Based Therapy for Diabetes: What

NINA MOINI: Do you have a sense for how big of a cost barrier there is for seniors right now

While lixisenatide and exenatide demonstrate relatively rapid and direct action within central circuits, liraglutide and semaglutide may exert their effects more slowly or indirectly, potentially relying on longer systemic exposure, slow diffusion, or action through peripheralcentral pathways

However, meta-analyses incorporating larger cohort studies have demonstrated no significant correlation with elevated pancreatic cancer risk, although the relatively brief duration of these cohort studies may influence these conclusions [25]

Renal Na(+)-glucose cotransporters

doi: 10.1186/s12933-016-0371-z